Found: 26
Select item for more details and to access through your institution.
Role of equilibrative nucleoside transporter 1 (ENT1) in the disposition of cytarabine in mice.
- Published in:
- Pharmacology Research & Perspectives, 2019, v. 7, n. 6, p. 1, doi. 10.1002/prp2.534
- By:
- Publication type:
- Article
A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/pharmaceutics14091933
- By:
- Publication type:
- Article
Imaging-Based Characterization of a Slco2b1 (-/-) Mouse Model Using [ 11 C]Erlotinib and [ 99m Tc]Mebrofenin as Probe Substrates.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 6, p. 918, doi. 10.3390/pharmaceutics13060918
- By:
- Publication type:
- Article
Influence of YES1 Kinase and Tyrosine Phosphorylation on the Activity of OCT1.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.644342
- By:
- Publication type:
- Article
Detection of Serum Deoxyribonucleic Acid Methylation Markers: A Novel Diagnostic Tool for Thyroid Cancer.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 1, p. 98, doi. 10.1210/jc.2005-1810
- By:
- Publication type:
- Article
High Prevalence and Possible de Novo Formation of BRAF Mutation in Metastasized Papillary Thyroid Cancer in Lymph Nodes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 9, p. 5265, doi. 10.1210/jc.2004-2353
- By:
- Publication type:
- Article
Uncommon Mutation, but Common Amplifications, of the PIK3CA Gene in Thyroid Tumors.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 8, p. 4688, doi. 10.1210/jc.2004-2281
- By:
- Publication type:
- Article
A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09917-0
- By:
- Publication type:
- Article
Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 766, doi. 10.3390/cancers13040766
- By:
- Publication type:
- Article
Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B.
- Published in:
- Molecules, 2022, v. 27, n. 20, p. 6815, doi. 10.3390/molecules27206815
- By:
- Publication type:
- Article
Darolutamide does not interfere with OATP‐mediated uptake of docetaxel.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 2, p. 314, doi. 10.1002/ijc.34922
- By:
- Publication type:
- Article
Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 10, p. 2322, doi. 10.1002/ijc.22110
- By:
- Publication type:
- Article
A phosphotyrosine switch regulates organic cation transporters.
- Published in:
- Nature Communications, 2016, v. 7, n. 3, p. 10880, doi. 10.1038/ncomms10880
- By:
- Publication type:
- Article
Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 527, doi. 10.1002/cpt.2638
- By:
- Publication type:
- Article
Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 461, doi. 10.1002/cpt.2605
- By:
- Publication type:
- Article
Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 1, p. 227, doi. 10.1002/cpt.1588
- By:
- Publication type:
- Article
Strategies to Reduce Solute Carrier‐Mediated Toxicity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 5, p. 799, doi. 10.1002/cpt.1185
- By:
- Publication type:
- Article
Evaluation of artemisinins for the treatment of acute myeloid leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Predicting Paclitaxel Disposition in Humans With Whole‐Body Physiologically‐Based Pharmacokinetic Modeling.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 12, p. 931, doi. 10.1002/psp4.12472
- By:
- Publication type:
- Article
Role for Drug Transporters in Chemotherapy‐Induced Peripheral Neuropathy.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 2, p. 460, doi. 10.1111/cts.12915
- By:
- Publication type:
- Article
DNA Methylation‐Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 1, p. 137, doi. 10.1111/cts.12861
- By:
- Publication type:
- Article
Interaction Between Sex and Organic Anion‐Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib‐N‐Oxide and Regorafenib‐Glucuronide in Mice.
- Published in:
- CTS: Clinical & Translational Science, 2019, v. 12, n. 4, p. 400, doi. 10.1111/cts.12630
- By:
- Publication type:
- Article
Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation.
- Published in:
- Molecules, 2021, v. 26, n. 18, p. 5500, doi. 10.3390/molecules26185500
- By:
- Publication type:
- Article
Activity of the Multikinase Inhibitor Sorafenib in Combination With Cytarabine in Acute Myeloid Leukemia.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 11, p. 893, doi. 10.1093/jnci/djr107
- By:
- Publication type:
- Article
Contribution of membrane transporters to chemotherapy‐induced cardiotoxicity.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, p. 36, doi. 10.1111/bcpt.13635
- By:
- Publication type:
- Article
Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14780-5
- By:
- Publication type:
- Article